Centessa Pharmaceuticals PLC ADR
Quarterly Financials
| Values in thousands | 2024-09-30 | 2024-06-30 | 2024-03-31 |
|---|---|---|---|
Revenue | $0 | $0 | $0 |
Gross Profit | -236 | -236 | -239 |
EBITDA | -40,395 | -43,793 | -34,776 |
EBIT | -40,631 | -44,029 | -35,015 |
Net Income | -43,816 | -43,865 | -38,024 |
Net Change In Cash | 0 | 0 | 0 |
Free Cash Flow | -40,580 | -37,264 | -37,286 |
Cash | 127,372 | 127,371 | 118,218 |
Basic Shares | 109,489 | 109,489 | 99,887 |
Annual Financials
| Values in thousands | 2023-12-31 | 2022-12-31 | 2020-12-31 |
|---|---|---|---|
Revenue | $6,853 | $0 | $0 |
Gross Profit | 6,853 | -130 | |
EBITDA | -166,066 | -212,263 | -10,434 |
EBIT | -166,879 | -212,393 | -10,440 |
Net Income | -151,085 | -216,207 | -11,041 |
Net Change In Cash | 6,853 | 0 | 0 |
Free Cash Flow | -160,511 | -201,683 | -10,630 |
Cash | 128,030 | 393,644 | 7,227 |
Basic Shares | 96,177 | 93,400 | 142,057 |
Earnings Calls
| Quarter | EPS |
|---|---|
2024-09-30 | -$0.37 |
2024-06-30 | -$0.40 |
2024-03-31 | -$0.38 |
2023-12-31 | -$0.38 |
